Literature DB >> 10536946

Is there a role for radical esophagectomy.

T Lerut1, W Coosemans, P De Leyn, G Decker, G Deneffe, D Van Raemdonck.   

Abstract

The aim of primary surgery in the treatment of carcinoma of the esophagus and gastroesophageal junction (GEJ) is definite cure. To obtain this goal R0 resection, i.e. complete macroscopic and microscopic removal is of paramount importance. However, one of the most controversial questions remains the extent of lymph node dissection, in particular the value of cervical lymph node dissection (the so called third field). Three arguments are believed to favour more extended lymphadenectomy: optimal staging, prolonged tumour control, improved cure rate. (a) Optimal staging: available data indicate that unforeseen lymph node involvement in the neck is encountered in approximately 30% of the patients after 3-field lymphadenectomy. Even in tumours of the GEJ up to 20% of the patients in the T3N+ setting have unforeseen positive nodes in the neck. (b) Prolonged tumour control: radical esophagectomy and extensive lymphadenectomy is decreasing locoregional recurrence substantially, below 10%, in several published reports. More over extended lymphadenectomy seems to defer onset of locoregional recurrence and generalised metastasis for up to 3 years or more. (c) Improved cure rate: despite a lack of prospective randomised study many studies indicate a distinct survival benefit after radical esophagectomy and extensive lymphadenectomy. From the available data it becomes clear that radical surgery and extensive lymphadenectomy offers the best chances for prolonged survival or cure. This can be done without increasing hospital mortality and morbidity. Survival figures obtained by this technique are a gold standard to which survival obtained by other techniques (e.g. multimodality treatment forms, VATS resections) have to be compared.

Entities:  

Mesh:

Year:  1999        PMID: 10536946     DOI: 10.1016/s1010-7940(99)00185-2

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

Review 1.  Hand-sewn versus stapled oesophago-gastric anastomosis: systematic review and meta-analysis.

Authors:  Sheraz R Markar; Alan Karthikesalingam; Soumil Vyas; Majid Hashemi; Mark Winslet
Journal:  J Gastrointest Surg       Date:  2011-01-27       Impact factor: 3.452

Review 2.  Optimal therapeutic strategies for resectable oesophageal or oesophagogastric junction cancer.

Authors:  Branislav Bystricky; Alicia F C Okines; David Cunningham
Journal:  Drugs       Date:  2011-03-26       Impact factor: 9.546

Review 3.  The extent of lymphadenectomy in esophageal resection for cancer should be standardized.

Authors:  Eliza R C Hagens; Mark I van Berge Henegouwen; Miguel A Cuesta; Suzanne S Gisbertz
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

4.  Total adventitial resection of the cardia: 'optimal local resection' for tumours of the oesophagogastric junction.

Authors:  A J Botha; W Odendaal; V Patel; T Watcyn-Jones; U Mahadeva; F Chang; H Deere
Journal:  Ann R Coll Surg Engl       Date:  2011-11       Impact factor: 1.891

5.  A critical appraisal of circumferential resection margins in esophageal carcinoma.

Authors:  Bareld B Pultrum; Judith Honing; Justin K Smit; Hendrik M van Dullemen; Gooitzen M van Dam; Henk Groen; Harry Hollema; John Th M Plukker
Journal:  Ann Surg Oncol       Date:  2010-03       Impact factor: 5.344

6.  Neoadjuvant chemotherapy for carcinoma of the oesophagus and oesophago-gastric junction: a six-year experience.

Authors:  Brian P Halliday; Richard Je Skipworth; Lucy Wall; Hamish A Phillips; Graeme W Couper; Andrew C de Beaux; Simon Paterson-Brown
Journal:  Int Semin Surg Oncol       Date:  2007-10-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.